Markers of Inflammation, Coagulation, and Renal Function Are Elevated in Adults with HIV Infection

Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men

Ridker, P. M., Cushman, M., Stampfer, M. J., Tracy, R. P., & Hennekens, C. H. (1997) · New England Journal of Medicine · doi:10.1056/nejm199704033361401 · Cited by 5,504

C-reactive protein: a critical update

Pepys, M. B., & Hirschfield, G. M. (2003) · Journal of Clinical Investigation · doi:10.1172/jci18921 · Cited by 4,694

Multi-Ethnic Study of Atherosclerosis: Objectives and Design

Bild, D. E. (2002) · American Journal of Epidemiology · doi:10.1093/aje/kwf113 · Cited by 3,942

CD4+ Count–Guided Interruption of Antiretroviral Treatment

The Strategies for Management of Antiretroviral Therapy (SMART) Study Group (2006) · New England Journal of Medicine · doi:10.1056/nejmoa062360 · Cited by 2,250

Prospective Study of C-Reactive Protein and the Risk of Future Cardiovascular Events Among Apparently Healthy Women

Ridker, P. M., Buring, J. E., Shih, J., Matias, M., & Hennekens, C. H. (1998) · Circulation · doi:10.1161/01.cir.98.8.731 · Cited by 1,642

. Inflammatory and coagulation biomarkers and mortality in patients with HIV infection.

Kuller, L. H., Tracy, R., Belloso, W., Wit, S. D., Drummond, F., Lane, H. C., Ledergerber, B., Lundgren, J., Neuhaus, J., Nixon, D., et al. (2008) · PLoS Medicine · doi:10.1371/journal.pmed.0050203 · Cited by 1,617

Associations of elevated interleukin-6 and C-reactive protein levels with mortality in the elderly

Harris, T. B., Ferrucci, L., Tracy, R. P., Corti, M. C., Wacholder, S., Ettinger, W. H., Heimovitz, H., Cohen, H. J., & Wallace, R. (1999) · The American Journal of Medicine · doi:10.1016/s0002-9343(99)00066-2 · Cited by 1,488

Cystatin C and the Risk of Death and Cardiovascular Events among Elderly Persons

Shlipak, M. G., Sarnak, M. J., Katz, R., Fried, L. F., Seliger, S. L., Newman, A. B., Siscovick, D. S., & Stehman‐Breen, C. O. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa043161 · Cited by 1,241

Relation of C-Reactive Protein and Coronary Heart Disease in the MRFIT Nested Case-Control Study

Kuller, L. H., Tracy, R. P., Shaten, J., & Meilahn, E. N. (1996) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a008963 · Cited by 1,098

Variability in the measurement of C-reactive protein in healthy subjects: implications for reference intervals and epidemiological applications

Macy, E. M., Hayes, T. E., & Tracy, R. P. (1997) · Clinical Chemistry · doi:10.1093/clinchem/43.1.52 · Cited by 797

Personalized gene therapy locks out HIV, paving the way to control virus without antiretroviral drugs

Levine, B. L., Leskowitz, R. M., & Suhoski, M. M. (2015) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.2015.1035644 · Cited by 5

Livedoid Vasculopathy Associated with HIV Infection in Two Patients: A Causal Relationship?

Hurabielle, C., Sébille, G., Barrou, B., Moguelet, P., Francès, C., & Barète, S. (2014) · Acta Dermato Venereologica · doi:10.2340/00015555-2338 · Cited by 5

Soluble membrane attack complex in the blood and cerebrospinal fluid of HIV-infected individuals, relationship to HIV RNA, and comparison with HIV negatives

Anderson, A. M. L., Schein, T. N., Kalapila, A. G., Lai, L., Waldrop‐Valverde, D., Moore, R. C., Franklin, D. R., Letendre, S. L., & Barnum, S. R. (2017) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2017.07.014 · Cited by 5

Carbohydrate, lipid, bone and inflammatory markers in HIV-positive adolescents on antiretroviral therapy and hormonal contraception

Landolt, N. K., Bunupuradah, T., Achalapong, J., Kosalaraksa, P., Petdachai, W., Ngampiyaskul, C., Ubolyam, S., Thammajaruk, N., Kerr, S. J., & Ananworanich, J. (2017) · Journal of Virus Eradication · doi:10.1016/s2055-6640(20)30297-1 · Cited by 5

Brief Report: Markers of Spontaneous Preterm Delivery in Women Living With HIV: Relationship With Protease Inhibitors and Vitamin D

Weinberg, A., Huo, Y., Kacanek, D., Patel, K., Watts, D. H., Wara, D. W., Hoffman, R. M., Klawitter, J., Christians, U., & for IMPAACT P1025 Team (2019) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0000000000002111 · Cited by 5

Comparison of in vitro fertilization cycles in couples with human immunodeficiency virus type 1 infection versus noninfected couples through a retrospective matched case-control study

Vianna, C. A., Dupont, C., Selleret, L., Canestri, A., Lévy, R., & Hamid, R. H. (2021) · F&S Reports · doi:10.1016/j.xfre.2021.04.008 · Cited by 5

Cardiovascular disease and HIV infection

Jachymek, M., Braksator, M., Parczewski, M., Peregud‐Pogorzelska, M., & Kaźmierczak, J. (2021) · HIV & AIDS Review · doi:10.5114/hivar.2021.107234 · Cited by 5

Lymphocyte–CRP Ratio and CRP–Albumin Ratio as Potential Inflammation Markers in Adults With HIV

Chenciner, L., Symonds, M., Dissanayake, O., Hunter, A., Burns, F. M., & Miller, R. F. (2022) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0000000000003028 · Cited by 5

Changes in Immune-Related Biomarkers and Endocannabinoids as a Function of Frequency of Cannabis Use in People Living With and Without HIV

Murray, C. H., Javanbakht, M., Cho, G. D., Gorbach, P. M., Fulcher, J. A., & Cooper, Z. D. (2023) · Cannabis and Cannabinoid Research · doi:10.1089/can.2022.0287 · Cited by 5

Immune markers, diurnal blood pressure profile and cardiac function in virologically suppressed HIV-infected patients

Manner, I. W., Waldum-Grevbo, B. E., Witczak, B. N., Bækken, M., Øktedalen, O., Os, I., Schwartz, T., & Sjaastad, I. (2017) · Blood Pressure · doi:10.1080/08037051.2017.1346459 · Cited by 4

Pre‐therapy inflammation and coagulation activation and long‐term CD4 count responses to the initiation of antiretroviral therapy

Achhra, A. C., Phillips, A. N., Emery, S., MacArthur, R. D., Furrer, H., Wit, S. D., Losso, M., Law, M. G., & International Network for Strategic Initiatives in Global HIV Trials (INSIGHT) Strategic Management of Antiretroviral Therapy (SMART) and Flexible Initial Retrovirus Suppressive Therapies (FIRST) study groups (2015) · HIV Medicine · doi:10.1111/hiv.12258 · Cited by 5

Evaluation of several serum interleukins as markers for treatment effectiveness in naïve HIV infected patients: A pilot study

Jianu, C., Itu-Mureşan, C., Drugan, C., Filipescu, I., Topan, A. V., Jianu, M. E., Morar, I. I., & Bolboaca, S. D. (2021) · PLoS ONE · doi:10.1371/journal.pone.0260007 · Cited by 4

Etiology of Persistent Microalbuminuria in Nigeria (P_MICRO study): protocol and study design

Wester, C. W., Shepherd, B. E., Wudil, U. J., Musa, B. M., Ingles, D. J., Prigmore, H. L., Dankishiya, F. S., Ahonkhai, A. A., Grema, B. A., Budge, P. J., et al. (2022) · BMC Infectious Diseases · doi:10.1186/s12879-022-07531-y · Cited by 4

Dietary pattern association with CD4 cells count in patients living with human immunodeficiency virus: A cross-sectional study

Keshani, P., Sarihi, S., Parsaie, N., & Joulaei, H. (2023) · Journal of Public Health Research · doi:10.1177/22799036231181200 · Cited by 5

Le vieillissement prématuré des patients infectés par le virus de l’immunodéficience humaine (VIH) : mise en évidence, recherche des mécanismes physiopatholo-giques et prise en charge

Capeau, J. (2011) · Bulletin de l Académie Nationale de Médecine · doi:10.1016/s0001-4079(19)31893-x · Cited by 4

Aortic Pressure Levels and Waveform Indexes in People Living With Human Immunodeficiency Virus: Impact of Calibration Method on the Differences With Respect to Non-HIV Subjects and Optimal Values

Díaz, A., Grand, M., Torrado, J., Salazar, F., Zócalo, Y., & Bia, D. (2021) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2021.772912 · Cited by 4

Cardiovascular Risk Prediction Equations Underestimate Risk in People Living with HIV: Comparison and Cut-point Redefinition for 19 Cardiovascular Risk Equations

Grand, M., Díaz, A., & Bia, D. (2022) · Current HIV Research · doi:10.2174/1570162x20666220126124149 · Cited by 6

Lipoprotein Profile in Immunological Non-Responders PLHIV after Antiretroviral Therapy Initiation

Masip, J., Jorba, R., López-Dupla, M., Domingo, P., Pacheco, Y. M., García‐Pardo, G., Martínez, E., Viladés, C., Veloso, S., Alba, V., et al. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23158071 · Cited by 4

The impact of cannabinoids on inflammasome signaling in HIV-1 infection

Min, A. K., Keane, A. M., Weinstein, M. P., & Swartz, T. H. (2023) · NeuroImmune Pharmacology and Therapeutics · doi:10.1515/nipt-2023-0002 · Cited by 5

Selected inflammatory and coagulation biomarkers pre-viral suppression in people with human immunodeficiency virus (HIV) infection without overt cardiovascular disease: Is there a need to redefine reference indices?

Louw, S. J., Mayne, E. S., Jacobson, B. F., & Mayne, A. L. H. (2023) · Cytokine · doi:10.1016/j.cyto.2023.156174 · Cited by 4

Association of HIV and viral suppression status with hospital acute kidney injury in the era of antiretroviral therapy

Fisher, M. C., Fazzari, M. J., Felsen, U. R., Hanna, D. B., Tappan, N., Wyatt, C. M., Abramowitz, M. K., & Ross, M. J. (2023) · Kidney International · doi:10.1016/j.kint.2023.07.022 · Cited by 4

Integrated Genetic and Cellular Analysis Reveals NLRP1 Activation in CD4+ T Lymphocytes During Chronic HIV Infection

Leal, V. N. C., Roa, M. E. G. V., Cantoni, J. S., dos Reis, E. C., Lara, A. N., & Pontillo, A. (2024) · Immunological Investigations · doi:10.1080/08820139.2024.2419940 · Cited by 4

Synergistic Activity of Second Mitochondrial-Derived Activator of Caspases Mimetic with Toll-like Receptor 8 Agonist Reverses HIV-1-Latency and Enhances Antiviral Immunity

Vlaming, K. E., Jansen, J., de Bree, G. J., Kootstra, N. A., & Geijtenbeek, T. B. H. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26062575 · Cited by 4

HIV-Infected Men with an Elevated Level of Serum Cystatin C have a High Likelihood of Developing Cancers

Yanagisawa, N., & Ando, M. (2012) · Journal of Antivirals & Antiretrovirals · doi:10.4172/jaa.1000044 · Cited by 4

Management of Antiretrovirals in Critically Ill Patients: Great Progress But Potential Pitfalls

Suffredini, D. A., George, J. M., & Masur, H. (2018) · Critical Care Medicine · doi:10.1097/ccm.0000000000003048 · Cited by 4

Impact of team‐based care on appropriate statin therapy prescribing in ***HIV‐infected patients

Hester, E. K., Caulder, C. R., & Penzak, S. R. (2020) · JACCP JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY · doi:10.1002/jac5.1206 · Cited by 4

Hepatitis B immunization data of patients living with HIV/AIDS: a multi-centre study

Öztürk, S., Özel, A. S., Ergen, P., Şenbayrak, S., & Ağalar, C. (2022) · Central European Journal of Public Health · doi:10.21101/cejph.a7300 · Cited by 4

Systemic inflammation and compromised intestinal barrier during successful treatment of HIV infection

Геннадьевна, Ш. Н., Владимирович, Ш. К., Korolevskaya, L. B., Сайдакова, Е. В., & Черешнев, В. А. (2016) · Clinical Medicine (Russian Journal) · doi:10.18821/0023-2149-2016-94-1-47-51 · Cited by 4

Lower endometrial receptivity in HIV-infected women receiving oocyte donation: a comorbidity of HIV infection?

Mataró, D., García, D., Coll, O., Vassena, R., & Rodríguez, A. (2017) · Human Reproduction Open · doi:10.1093/hropen/hox019 · Cited by 4

Brief Report: Racial Comparison of D-Dimer Levels in US Male Military Personnel Before and After HIV Infection and Viral Suppression

O’Bryan, T. A., Agan, B. K., Tracy, R. P., Freiberg, M. S., Okulicz, J. F., So‐Armah, K., Ganesan, A., Rimland, D., Lalani, T., Deiss, R., et al. (2018) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0000000000001626 · Cited by 4

Evaluation of Some Cytokines, CD4, Hepcidin, Iron, and Some Haematological Parameters of Patients Living with Human Immunodeficiency Virus in Southeastern Part of Nigeria

Obeagu, E. I., Kalu, O., Ogbu, I. S. I., Esimai, B. N., Ugwuja, M. C., Ogbu, C. P., & Asogwa, E. I. (2020) · Journal of Pharmaceutical Research International · doi:10.9734/jpri/2020/v32i1430599 · Cited by 4

von Willebrand factor propeptide‐to‐antigen ratio in HIV‐infected pregnancy: Evidence of endothelial activation

Schapkaitz, E., Libhaber, E. N., Jacobson, B. F., Meiring, M., & Buller, H. R. (2021) · Journal of Thrombosis and Haemostasis · doi:10.1111/jth.15502 · Cited by 4

Pregnancy Related Venous Thromboembolism-Associated with HIV Infection and Antiretroviral Therapy

Schapkaitz, E., Jacobson, B. F., & Libhaber, E. N. (2022) · Seminars in Thrombosis and Hemostasis · doi:10.1055/s-0042-1754391 · Cited by 4

Thromboelastography on plasma reveals delayed clot formation and accelerated clot lyses in HIV-1 infected persons compared with healthy controls

Rönsholt, F. F., Gerstoft, J., Ullum, H., Johansson, P. I., Katzenstein, T. L., & Ostrowski, S. R. (2015) · BMC Infectious Diseases · doi:10.1186/s12879-015-1124-4 · Cited by 4

High-density lipoprotein-cholesterol levels and risk of cancer in HIV-infected subjects

Squillace, N., Galli, L., Bandera, A., Castagna, A., Madeddu, G., Caramello, P., Antinori, A., Cattelan, A. M., Maggiolo, F., Cingolani, A., et al. (2016) · Medicine · doi:10.1097/md.0000000000004434 · Cited by 4

Porphyromonas gingivalis antibody levels and diagnosis of coronary artery disease in HIV ‐positive individuals

Berquist, V., Hearps, A. C., Ford, P. J., Jaworowski, A., Leishman, S. J., Hoy, J., & Trevillyan, J. M. (2017) · Journal of Periodontal Research · doi:10.1111/jre.12460 · Cited by 4

Monocyte-derived Dll4 is a novel contributor to persistent systemic inflammation in HIV patientsPreprint

Wang, S., Singh, M. V., Yang, H., Morrell, C. N., Mohamad, L. A., Xu, J. J., Nguyen, T., Ture, S. K., Tyrell, A., Maggirwar, S. B., et al. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.04.18.537330 · Cited by 4

Cumulative HIV viral load and lower CD4+ cell count are associated with incident venous thromboembolism in people with HIV

Ruderman, S. A., Nance, R. M., Crane, H. M., Cachay, E. R., Kitahata, M. M., Napravnik, S., Whitney, B. M., Heckbert, S. R., Attia, E. F., Longenecker, C. T., et al. (2024) · AIDS · doi:10.1097/qad.0000000000004095 · Cited by 3

Long‐Term Clinical Outcomes After Autologous Hematopoietic Stem Cell Transplantation in 49 Individuals Living With HIV (PLWH) and Affected by High‐Risk or Relapsed Lymphoma: A European Experience of Continued Relevance for PLWH

Zanet, E., Taborelli, M., Tirelli, U., Díez-Martín, J. L., Balsalobre, P., Re, A., Rupolo, M., Mazzucato, M., Cwynarski, K., Gomez, M. R. V., et al. (2025) · Journal of Medical Virology · doi:10.1002/jmv.70165 · Cited by 3

Optimizing statin therapy in HIV-infected patients: a review of pharmacotherapy considerations

Ansari, R., Khalili, H., & Mohammadi, K. (2025) · BMC Cardiovascular Disorders · doi:10.1186/s12872-025-04887-2 · Cited by 3

Increased immune activation in people living with HIV on antiretroviral therapy but not when compared with persons on HIV preexposure prophylaxis

Robertson, J., Edén, A., Yilmaz, A., Andersson, L., Hagberg, L., Nyström, K., Nilsson, S., Treutiger, C.-J., Tunbäck, P., Gostner, J. M., et al. (2025) · Scandinavian Journal of Infectious Diseases · doi:10.1080/23744235.2025.2515157 · Cited by 3

Cardiovascular disease management and prevention: the new frontier in the management of patients with human immunodeficiency virus infection

Kerferd, J., Limaye, S., & Gnanenthiran, S. R. (2025) · Internal Medicine Journal · doi:10.1111/imj.70223 · Cited by 3

HDL dysfunction: a role in the pathogenesis of cardiometabolic syndrome in chronic HIV infection?

Markakis, K., Abadi, L. F., Kombe, A. J. K., Christodoulides, M., & Kelesidis, T. (2025) · Metabolism · doi:10.1016/j.metabol.2025.156432 · Cited by 3

The Impact of Past and Current Alcohol Consumption Patterns on Progression of Carotid Intima‐Media Thickness Among Women and Men Living with HIV Infection

Chichetto, N. E., Plankey, M. W., Abraham, A. G., Sheps, D. S., Ennis, N., Chen, X., Weber, K. M., SHOPTAW, S. J., Kaplan, R. C., Post, W. S., et al. (2019) · Alcoholism Clinical and Experimental Research · doi:10.1111/acer.13974 · Cited by 3

The quality of SIV-specific fCD8 T cells limits SIV RNA production in Tfh cells during antiretroviral therapy

Takahama, S., Washizaki, A., Okamura, T., Kitamura, S., Nogimori, T., Satou, Y., Yasutomi, Y., Yoshinaga, T., & Yamamoto, T. (2024) · Journal of Virology · doi:10.1128/jvi.00812-24 · Cited by 3

HIV and Inflamm-Aging: How Do We Reach the Summit of Healthy Aging?

Sheets, K. M., & Baker, J. V. (2024) · PubMed Central · Cited by 3

Mitochondrial DNA Haplogroups, Biomarkers of Inflammation and Immune Activation, and Risk of Diabetes in Veterans With and Without Human Immunodeficiency Virus

Yan, A., Kundu, S., Samuels, D. C., Bailin, S. S., Xu, K., So‐Armah, K., Butt, A. A., Gerschenson, M., Goetz, M. B., Doyle, M. F., et al. (2025) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiaf304 · Cited by 3

Infectious and Non-infectious Etiologies of Cardiovascular Disease in Human Immunodeficiency Virus Infection

Chastain, D. B., King, S. T., & Stover, K. R. (2016) · The Open AIDS Journal · doi:10.2174/1874613601610010113 · Cited by 3

The additive effect of type 2 diabetes on fibrinogen, von Willebrand factor, tryptophan and threonine in people living with HIV

Harrison, M., Wolfe, A. S., Fordyce, J., Rock, J. L., García, A. A., & Zuniga, J. A. (2019) · Amino Acids · doi:10.1007/s00726-019-02715-4 · Cited by 3

Calculadoras de riesgo cardiovascular en personas viviendo con el virus de la inmunodeficiencia humana

Grand, M., Díaz, A., & Bia, D. (2020) · Hipertensión y Riesgo Vascular · doi:10.1016/j.hipert.2020.06.004 · Cited by 3

HIV-Associated Neurocognitive Disorders and Delirium

Hirsch, C. H., Stewart, A. L., Sales, P. M. G., Pereira, L. F., & Bourgeois, J. A. (2021) · Springer eBooks · doi:10.1007/978-3-030-80665-1_10 · Cited by 3

Effect of non-nucleoside reverse transcriptase inhibitors and protease inhibitors on serum levels of myeloperoxidase and C-reactive protein in HIV-infected individuals

Borato, D. C. K., Kalva‐Filho, C. A., Machado, E. P., Barbosa, C. R., & Vellosa, J. C. R. (2022) · Brazilian Journal of Pharmaceutical Sciences · doi:10.1590/s2175-97902020000118780 · Cited by 3

Factors associated with the risk of upper respiratory tract bacterial infections among HIV-positive patients

Skrzat‐Klapaczyńska, A., Paciorek, M., Firląg‐Burkacka, E., Horban, A., & Kowalska, J. D. (2022) · PLoS ONE · doi:10.1371/journal.pone.0270770 · Cited by 3

Higher HIV-1 Env gp120-Specific Antibody-Dependent Cellular Cytotoxicity (ADCC) Activity Is Associated with Lower Levels of Defective HIV-1 Provirus

Yucha, R., Litchford, M. L., Fish, C. S., Yaffe, Z. A., Richardson, B. A., Maleche‐Obimbo, E., John-Stewart, G. C., Wamalwa, D. C., Overbaugh, J. M., & Lehman, D. A. (2023) · Viruses · doi:10.3390/v15102055 · Cited by 4

Disturbances in the gut microbiota potentially associated with metabolic syndrome among patients living with HIV-1 and on antiretroviral therapy at Bafoussam Regional Hospital, Cameroon

Diesse, J. M., Jadhav, S., Tamekou, S. L., Simo, G., Dzoyem, J. P., Souopgui, J., Kuiate, J., & Nema, V. (2025) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-025-01653-4 · Cited by 3

Estimation and Assessment of Plasma D-Dimer Levels in HIV Patients

Himmat, W. H. H., & Gaufri, N. E. A. M. (2016) · Journal of Biosciences and Medicines · doi:10.4236/jbm.2016.410001 · Cited by 3

Are antiretrovirals enough for people living with HIV?

Phillips, A. N., Baker, J., & Lundgren, J. D. (2013) · The Lancet · doi:10.1016/s0140-6736(13)62072-3 · Cited by 3

New Approach for Inhibition of HIV Entry: Modifying CD4 Binding Sites by Thiolated Pyrimidine Derivatives

Kanizsai, S., Ongrádi, J., Aradi, J., & Nagy, K. (2016) · Pathology & Oncology Research · doi:10.1007/s12253-016-0044-y · Cited by 3

Second European Round Table on the Future Management of HIV

Rokx, C., Richman, D. D., Müller-Trutwin, M. C., Silvestri, G., van Lunzen, J., Khoo, S., Lichterfeld, M. D., Altfeld, M. A., Perno, C. F., Hunt, P. W., et al. (2015) · Journal of Virus Eradication · doi:10.1016/s2055-6640(20)30497-0 · Cited by 3

HIV Infection Rather than Concurrent Opportunistic Infections drives Most Systemic Procoagulant, Vascular and Damage Responses – a Prospective Cohort Study in Central Africa

Janssen, S., Huson, M. A. M., Osbak, K. K., Rossatanga, E. G., Alabi, A. S., Lutter, R., Grobusch, M. P., & van der Poll, T. (2016) · Antiviral Therapy · doi:10.3851/imp3100 · Cited by 3

Cross-sectional study of CD4

Pollock, K. M., Pintilie, H., Foster, C., & Fidler, S. J. (2018) · Medicine · doi:10.1097/md.0000000000009798 · Cited by 3

HIV infection is independently associated with a higher concentration of alpha‐1 antitrypsin

Thudium, R. F., Lundgren, J. D., Benfield, T., Nordestgaard, B. G., Borges, Á. H., Gerstoft, J., Nielsen, S. D., Ronit, A., & the Copenhagen Co‐morbidity in HIV Infection (COCOMO) Study Group (2018) · HIV Medicine · doi:10.1111/hiv.12666 · Cited by 3

Association between Antiretroviral Treatment and Markers of Systemic Inflammation among HIV Patients in Ghana

Haile, Z. T., Sarfo, B. Y., Bonney, E. Y., Mensah, E. A., & Deletsu, S. D. (2020) · Current HIV Research · doi:10.2174/1570162x18666200817111152 · Cited by 3

The Association Between Peripheral Oxytocin Levels and Depressive Symptoms in People With HIV

Shortell, D. D., Rubin, L. H., Murphy, A. J., Cohen, R. A., & Porges, E. C. (2022) · Psychosomatic Medicine · doi:10.1097/psy.0000000000001122 · Cited by 3

Commentary: Long-Term Changes of Inflammatory Biomarkers in Individuals on Suppressive Three-Drug or Two-Drug Antiretroviral Regimens

Llibre, J. M., Cahn, P. E., & Barber, T. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.904689 · Cited by 3

Serum reference intervals of micronutrients, vitamins, and interleukins among healthy adults in South-Western Nigeria

Adedeji, T. A., Adedeji, N. O., Jeje, O. A., Ajeigbe, A. K., Smith, O. S., Owojuyigbe, T. O., Fawale, B., Ajose, O. A., Adebisi, S., Akande, A. A., et al. (2024) · Practical Laboratory Medicine · doi:10.1016/j.plabm.2024.e00363 · Cited by 2

Comparison of oral and gut microbiome highlights the role of oral bacteria in systemic inflammation in HIV

Fulcher, J. A., Newman, K., Pham, B., Li, D., Cho, G. D., Elliott, J. E., Tobin, N. H., SHOPTAW, S. J., Gorbach, P. M., & Aldrovandi, G. M. (2026) · mSphere · doi:10.1128/msphere.00384-26 · Cited by 2

Perceptions of body size and non-communicable disease risk among people with HIV in Nairobi, Kenya: an explanatory mixed-methods study

Suvada, K., Kocher, E. L., Chung, M. H., Kundu, C., Moraa, H., Ngumbau, N. M., Maina, C. N., Brunissen, L., Ali, M. K., Kinuthia, J., et al. (2025) · BMJ Global Health · doi:10.1136/bmjgh-2024-016546 · Cited by 2

The Impact of Semaglutide on Weight Loss and Inflammation in People with HIV. An Observational Prospective Study in Greek Population

Petrakis, V., Rafailidis, P. I., Panopoulou, M. I., Konstantinidis, T. G., Tsantes, A. G., Babaka, N., Papazoglou, D., & Panagopoulos, P. (2025) · Experimental and Clinical Endocrinology & Diabetes · doi:10.1055/a-2737-6227 · Cited by 2

Treatment in acute HIV infection only temporarily preserves monocyte function: a comparative cohort study in adult males

Vlaming, K. E., van Paassen, P. M., van Hamme, J. L., Schonherr, S., Kaptein, T. M., van Dort, K. A., Maurer, I., van Crevel, R., Rokx, C., Vogt, L., et al. (2025) · EBioMedicine · doi:10.1016/j.ebiom.2025.105997 · Cited by 2

Functional and Transcriptional Senescence Profiles of CD8+ T Cells Associate With the Presence of Carotid Plaques in People Living With HIV

Blaauw, M. J. T., Navas, A., Rios-Vazquez, V., Vadaq, N., Berrevoets, M. A. H., Otten, T., Vos, W. A. J. W., van Eekeren, L. E., Groenendijk, A. L., Weijers, G., et al. (2026) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiag018 · Cited by 2

Impact of SGLT2 Inhibitors on Kidney Function Among People With HIV: A US Prospective Multisite Study

Haidar, L., Crane, H. M., Nance, R. M., Doupe, M. B., Leong, C., Bamford, L. P., Burkholder, G., Cachay, E. R., Christopoulos, K., Commanday, A., et al. (2026) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0000000000003854 · Cited by 2

Prevalence of Proteinuria and Elevated Serum Cystatin C among HIV-Infected Adolescents in the Reaching for Excellence in Adolescent Care and Health (REACH) Study

Aaron, K. J., Kempf, M.-C., Christenson, R. H., Wilson, C. M., Muntner, P., & Shrestha, S. (2012) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0b013e31826d7421 · Cited by 2

The relationship between diabetes and depressive symptoms in men with or at risk of HIV infection

Basil, R., Brown, T. T., Haberlen, S., Rubin, L., Plankey, M. W., Becker, J. T., Lake, J. E., Palella, F., & Sarkar, S. (2020) · HIV Medicine · doi:10.1111/hiv.12958 · Cited by 2

Immune correlates of cardiovascular co-morbidity in HIV infected participants from South India

Kausalya, B., Saravanan, S., Pallikkuth, S., Pahwa, R., Saini, S. R., Iqbal, H. S., Solomon, S. S., Murugavel, K. G., Poongulali, S., Kumarasamy, N., et al. (2022) · BMC Immunology · doi:10.1186/s12865-022-00498-0 · Cited by 2

Implications of vascular depression for successful cognitive aging in HIV Disease

Mustafa, A. I., Beltran‐Najera, I., Evans, D., Bartlett, A., Dotson, V. M., & Woods, S. P. (2024) · Journal of NeuroVirology · doi:10.1007/s13365-024-01201-2 · Cited by 3

Brief Report: Low-Dose Methotrexate Does Not Affect Measures of HIV-1 Persistence in Individuals With Chronically Treated HIV-1 Infection

Cyktor, J. C., Yeh, E., Ribaudo, H. J., Hoeth, D., Naqvi, A., Bell, T. K., Ridker, P. M., Fichtenbaum, C. J., Daar, E. S., Havlir, D. V., et al. (2024) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0000000000003453 · Cited by 3

Assessing renal function with the use of cystatin C in a rural cohort of people living with HIV on highly active antiretroviral therapy within the Limpopo Province, South Africa

Choshi, J., Flepisi, B. T., Mabhida, S. E., Sekgala, M. D., Mokoena, H., Nkambule, B. B., Ndwandwe, D. E., Mchiza, Z. J., Kengne, A. P., Dludla, P. V., et al. (2024) · Discover Applied Sciences · doi:10.1007/s42452-024-06197-2 · Cited by 2

HIV-1 controllers exhibit an enhanced antiretroviral innate state characterised by overexpression of p21 and MCPIP1 and silencing of ERVK-6 RNA expression

de Azevedo, S. S. D., Alves, M. R., Côrtes, F. H., Delatorre, E. O., Hoagland, B., Villela, L. M., Grinsztejn, B. G. J., Veloso, V. G., Morgado, M. G., Souza, T. M. L., et al. (2024) · Memórias do Instituto Oswaldo Cruz · doi:10.1590/0074-02760240071 · Cited by 2

Oral Microbiome and Dental Caries in Kenyan Children and Adolescents Living with HIV

Wang, Y., Matangkasombut, O., Kemoli, A., John-Stewart, G. C., Benki-Nugent, S. F., Slyker, J. A., Aldrovandi, G. M., & Seminario, A. L. (2025) · JDR Clinical & Translational Research · doi:10.1177/23800844241311862 · Cited by 2

Markers of Inflammation and Immune Dysfunction and Non-AIDS Cancer Risk in Adults With HIV

Izquierdo, R., Vallejo, A., Suárez‐García, I., Martín-Hondarza, A., Gutiérrez, F., Pérez-Molina, J. A., García, D. V., Macı́as, J., Rivero, A., Olalla, J., et al. (2025) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0000000000003667 · Cited by 3

Krill Oil for HIV-Related Inflammation: A Pilot Study

Swanson, B. A., Keithley, J. K., Fogg, L., Adeyemi, O. M., & Sha, B. E. (2014) · Alternative and Complementary Therapies · doi:10.1089/act.2014.20307 · Cited by 2

Serum Interleukin-6 and Weight Loss in Antiretroviral-naïve and Antiretroviral-treated Patients with HIV/AIDS: Relationships and Predictors

Adedeji, T. A., Adedeji, N. O., Ajeigbe, A. K., Smith, O. S., Jeje, O. A., Fawale, B., Ajose, A. O., Adebisi, S., Akande, A. A., & Okesina, B. A. (2022) · Current HIV Research · doi:10.2174/1570162x20666220901085926 · Cited by 2

The effect of mentholated cigarette use on interleukin-6 responses across different HIV positive race/ethnic subgroups

Míguez‐Burbano, M. J. (2010) · International Journal of Interferon Cytokine and Mediator Research · doi:10.2147/ijicmr.s12392 · Cited by 2

High frequencies of PMN-MDSCs are associated with low suppressive capacity in advanced stages of HIV-1 infection

Grützner, E. M., Neizert, A., Stirner, R., Conca, R., Andrä, I., Wolff, L. S., Schiemann, M., Holdt, L. M., Klein, C., Bogner, J. R., et al. (2020) · Translational Medicine Communications · doi:10.1186/s41231-019-0052-5 · Cited by 2

Emerging risk factors for QT interval prolongation and torsades de pointes

Lazzerini, P. E., Pasini, F. L., Capecchi, P. L., & Boutjdir, M. (2022) · Elsevier eBooks · doi:10.1016/b978-0-12-821446-6.00009-2 · Cited by 2

Interferon gamma, interleukin 6 and tissue necrosis factor alpha levels among asymptomatic HIV patients in Benin City, Nigeria

AIKPITANYI-IDUITUA, G. A., Ibeh, I. N., Idemudia, N. L., Aikpitanyi-Iduitua, R. O., & Omoregie, R. (2023) · Human Antibodies · doi:10.3233/hab-220014 · Cited by 2

Kidney markers predict mortality in patients with HIV disease

Kopp, J. B. (2011) · Nature Reviews Nephrology · doi:10.1038/nrneph.2011.27 · Cited by 2

Incidence of benign prostate hypertrophy in Danish men with and without HIV infection

Ahlström, M. G., Kronborg, G., Larsen, C. S., Pedersen, C., Pedersen, G., Gerstoft, J., & Obel, N. (2015) · AIDS · doi:10.1097/qad.0000000000000804 · Cited by 2

Comparison of bead array and glass nanoreactor multi-analyte platforms for the evaluation of CNS and peripheral inflammatory markers during HIV infection

Anderson, A. M. L., Nguyen, M. L., Potter, M., Cookson, D. R., Kempińska, K., Ellis, R. J., Diccianni, M. B., & Letendre, S. L. (2018) · Journal of Immunological Methods · doi:10.1016/j.jim.2018.11.008 · Cited by 2

Factores inmunológicos relacionados con VIH-1 en pacientes colombianos

Marín-Palma, D., Cardona‐Arias, J. A., & Juan Carlos Hernández, S. D. (2019) · Revista Ciencias de la Salud · doi:10.12804/revistas.urosario.edu.co/revsalud/a.7927 · Cited by 2

Towards simultaneous quantification of protease inhibitors and inflammatory biomarkers in serum for people living with HIV

Wang, P., Venuto, C. S., Cha, R., & Miller, B. L. (2020) · Analytical Methods · doi:10.1039/d0ay00098a · Cited by 2

The effect of statin therapy on pneumonia in an HIV-infected population in the Netherlands

Janssen, N. E., van Lelyveld, S. F. L., Hoepelman, A. I. M., Gras, L. A., Groenwold, R. H. H., & Oosterheert, J. J. (2013) · Journal of Infection · doi:10.1016/j.jinf.2013.04.011 · Cited by 2

A Single-Cell Molecular Atlas of White Adipose Tissue Shows Differences in Myeloid and Lymphoid Cell Polarization in Type 2 Diabetes and HIV InfectionPreprint

Bailin, S. S., Kropski, J. A., Gangula, R., Hannah, L., Simmons, J. D., Mashayekhi, M., Ye, F., Fan, R., Chopra, A., Ram, R., et al. (2022) · SSRN Electronic Journal · doi:10.2139/ssrn.4097122 · Cited by 2

No evidence of a synergistic effect of HIV infection and diabetes mellitus type 2 on fat distribution, plasma adiponectin or inflammatory markers

Hove‐Skovsgaard, M., Abildgaard, J., Gelpi, M., Gaardbo, J. C., Kolte, L., Ullum, H., Trøseid, M., Lindegaard, B., & Nielsen, S. D. (2020) · BMC Infectious Diseases · doi:10.1186/s12879-020-05594-3 · Cited by 1

Thrombotic thrombocytopenic purpura in HIV-infected patients: new twists on an old disease

Louw, S. J., Gededzha, M. P., Mayne, A. L. H., & Mayne, E. S. (2022) · AIDS · doi:10.1097/qad.0000000000003257 · Cited by 1

Aortic aneurysms and markers of platelet activation, hemostasis, and endothelial disruption in people living with HIV

Grønbæk, S. K., Høgh, J., Knudsen, A. D., Pham, M. H. C., Sigvardsen, P. E., Fuchs, A., Kühl, J. T., Køber, L., Gerstoft, J., Benfield, T., et al. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1115894 · Cited by 1

Coronary heart disease in patients with human immunodeficiency virus infection

Alieva, A. M., Batov, M. A., Skripnichenko, E. A., Teplova, N. V., Baykova, I. E., Valiev, R. K., Фатхуллаевна, А. М., Kotikova, I. A., Алмардонович, М. А., & Nikitin, I. G. (2023) · Russian Medicine · doi:10.17816/medjrf112317 · Cited by 1

Unveiling neuroimmunology profile of immunological non-responders in HIV: a multimodal MRI approach

Zhang, Y., Ji, J., Zheng, L., Cai, M., Sun, G., Ma, Y., Zhang, X., Chen, X., Zhang, Y., Lin, X., et al. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1452532 · Cited by 1

Perspective: clinical relevance of epigenetic aging and HIV

Schoepf, I. C., Haerry, D., Esteban-Cantos, A., Arribas, J. R., TARR, P. E., & Study, T. S. H. C. (2025) · Epigenomics · doi:10.1080/17501911.2025.2491299 · Cited by 1

HIV Status, Burden of Comorbid Disease, and Biomarkers of Inflammation, Altered Coagulation, and Monocyte Activation

So‐Armah, K., McGinnis, K. A., Baker, J. V., Gibert, C. L., Butt, A. A., Bryant, K. J., Goetz, M. B., Tracy, R. P., Oursler, K. K., Rimland, D., et al. (2012) · Clinical Infectious Diseases · doi:10.1093/cid/cis406 · Cited by 264

Markers of inflammation and activation of coagulation are associated with anaemia in antiretroviral-treated HIV disease

Borges, Á. H., Weitz, J. I., Collins, G., Baker, J. V., Lévy, Y., Davey, R. T., Phillips, A. N., Neaton, J. D., Lundgren, J. D., & Deeks, S. G. (2014) · AIDS · doi:10.1097/qad.0000000000000344 · Cited by 31

Relationship Between Inflammatory and Coagulation Biomarkers and Cardiac Autonomic Function in HIV-Infected Individuals

Young, L. C., Roediger, M. P., Grandits, G., Baker, J. V., Somboonwit, C., Williams, I. G., Lundgren, J. D., Neaton, J. D., & Soliman, E. Z. (2014) · Biomarkers in Medicine · doi:10.2217/bmm.14.27 · Cited by 12

Inflammation, Coagulation and Cardiovascular Disease in HIV-Infected Individuals

Duprez, D. A., Neuhaus, J., Kuller, L. H., Tracy, R. P., Belloso, W. H., Wit, S. D., Drummond, F., Lane, H. C., Ledergerber, B., Lundgren, J. D., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0044454 · Cited by 536

Biomarkers of inflammation, coagulation and microbial translocation in HIV/HCV co-infected patients in the SMART study

Peters, L., Neuhaus, J., Duprez, D. A., Neaton, J. D., Tracy, R. P., Klein, M. B., Mocroft, A., Rockstroh, J. K., Dore, G. J., & Lundgren, J. D. (2014) · Journal of Clinical Virology · doi:10.1016/j.jcv.2014.03.017 · Cited by 28